PULLING BACK THE CURTAIN ON PBMS: A PATH TOWARDS AFFORDABLE PRESCRIPTION DRUGS
Prescription drug prices in the United States continue to rise with no end in sight. Individuals are foregoing other needs to pay for their medicines while healthcare companies continue to rake in enormous profits. In this Essay, I discuss how Americans can reverse this oppressive drug pricing trend...
Gespeichert in:
| Veröffentlicht in: | Harvard journal on legislation 2022-07, Vol.59 (2), p.257 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | 257 |
| container_title | Harvard journal on legislation |
| container_volume | 59 |
| creator | "Buddy" Carter, Earl L |
| description | Prescription drug prices in the United States continue to rise with no end in sight. Individuals are foregoing other needs to pay for their medicines while healthcare companies continue to rake in enormous profits. In this Essay, I discuss how Americans can reverse this oppressive drug pricing trend. As both a pharmacist and a member of Congress, I explain why drug prices are so high from a unique perspective, and illuminate what patients and Congress can do to bring prices down and advocate for a better system. After discussing various actors involved with prescription drug pricing, this Essay then focuses on Pharmacy Benefit Managers ("PBMs") as the clandestine menace of the healthcare industry. This Essay utilizes first-hand stories from patients, pharmacists, and doctors to illustrate why PBMs need to be exposed and held accountable. Most importantly, this Essay will provide a legislative framework for making lower drug prices a reality. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2705443254</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2705443254</sourcerecordid><originalsourceid>FETCH-LOGICAL-p113t-bd22b36db1e147a649a21105e48207bd087b52376a59801aec407c6a8fd4f38d3</originalsourceid><addsrcrecordid>eNotjVtLwzAARoM4sG7-h4DPhVyb1Lf0XoxtSFPc20jX9mGIm-v2_y3o08eBw_keQIBjRkOOxP4RBAhhEUok90_geVlOK-KIxwFoTK913ZQwUek7dFUO0946VTewbaBJPro3qKBRroKu_VQ266AqitZmKtE5NDbvUlsbV69yZvuy24HN7L-W6eV_t6AvcpdWoW7LOlU6vGBMb-EwEjLQaBzwhJnwEYs9wRjxiUmCxDAiKQZOqIg8jyXCfjoyJI6Rl_PIZipHugWvf93L9fxzn5bb4XS-X7_XywMRiDNGCWf0F_CUQxI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2705443254</pqid></control><display><type>article</type><title>PULLING BACK THE CURTAIN ON PBMS: A PATH TOWARDS AFFORDABLE PRESCRIPTION DRUGS</title><source>PAIS Index</source><source>Worldwide Political Science Abstracts</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>HeinOnline Law Journal Library</source><creator>"Buddy" Carter, Earl L</creator><creatorcontrib>"Buddy" Carter, Earl L</creatorcontrib><description>Prescription drug prices in the United States continue to rise with no end in sight. Individuals are foregoing other needs to pay for their medicines while healthcare companies continue to rake in enormous profits. In this Essay, I discuss how Americans can reverse this oppressive drug pricing trend. As both a pharmacist and a member of Congress, I explain why drug prices are so high from a unique perspective, and illuminate what patients and Congress can do to bring prices down and advocate for a better system. After discussing various actors involved with prescription drug pricing, this Essay then focuses on Pharmacy Benefit Managers ("PBMs") as the clandestine menace of the healthcare industry. This Essay utilizes first-hand stories from patients, pharmacists, and doctors to illustrate why PBMs need to be exposed and held accountable. Most importantly, this Essay will provide a legislative framework for making lower drug prices a reality.</description><identifier>ISSN: 0017-808X</identifier><identifier>EISSN: 1943-507X</identifier><language>eng</language><publisher>Cambridge: Harvard University Law School - Harvard Journal on Legislation</publisher><subject>Drug prices ; Health care industry ; Health services ; Legislatures ; Patients ; Pharmaceutical industry ; Pharmacists ; Prices ; Profits</subject><ispartof>Harvard journal on legislation, 2022-07, Vol.59 (2), p.257</ispartof><rights>Copyright Harvard University Law School - Harvard Journal on Legislation Summer 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27843</link.rule.ids></links><search><creatorcontrib>"Buddy" Carter, Earl L</creatorcontrib><title>PULLING BACK THE CURTAIN ON PBMS: A PATH TOWARDS AFFORDABLE PRESCRIPTION DRUGS</title><title>Harvard journal on legislation</title><description>Prescription drug prices in the United States continue to rise with no end in sight. Individuals are foregoing other needs to pay for their medicines while healthcare companies continue to rake in enormous profits. In this Essay, I discuss how Americans can reverse this oppressive drug pricing trend. As both a pharmacist and a member of Congress, I explain why drug prices are so high from a unique perspective, and illuminate what patients and Congress can do to bring prices down and advocate for a better system. After discussing various actors involved with prescription drug pricing, this Essay then focuses on Pharmacy Benefit Managers ("PBMs") as the clandestine menace of the healthcare industry. This Essay utilizes first-hand stories from patients, pharmacists, and doctors to illustrate why PBMs need to be exposed and held accountable. Most importantly, this Essay will provide a legislative framework for making lower drug prices a reality.</description><subject>Drug prices</subject><subject>Health care industry</subject><subject>Health services</subject><subject>Legislatures</subject><subject>Patients</subject><subject>Pharmaceutical industry</subject><subject>Pharmacists</subject><subject>Prices</subject><subject>Profits</subject><issn>0017-808X</issn><issn>1943-507X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>7TQ</sourceid><sourceid>7UB</sourceid><recordid>eNotjVtLwzAARoM4sG7-h4DPhVyb1Lf0XoxtSFPc20jX9mGIm-v2_y3o08eBw_keQIBjRkOOxP4RBAhhEUok90_geVlOK-KIxwFoTK913ZQwUek7dFUO0946VTewbaBJPro3qKBRroKu_VQ266AqitZmKtE5NDbvUlsbV69yZvuy24HN7L-W6eV_t6AvcpdWoW7LOlU6vGBMb-EwEjLQaBzwhJnwEYs9wRjxiUmCxDAiKQZOqIg8jyXCfjoyJI6Rl_PIZipHugWvf93L9fxzn5bb4XS-X7_XywMRiDNGCWf0F_CUQxI</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>"Buddy" Carter, Earl L</creator><general>Harvard University Law School - Harvard Journal on Legislation</general><scope>7TQ</scope><scope>7UB</scope><scope>DHY</scope><scope>DON</scope></search><sort><creationdate>20220701</creationdate><title>PULLING BACK THE CURTAIN ON PBMS: A PATH TOWARDS AFFORDABLE PRESCRIPTION DRUGS</title><author>"Buddy" Carter, Earl L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p113t-bd22b36db1e147a649a21105e48207bd087b52376a59801aec407c6a8fd4f38d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Drug prices</topic><topic>Health care industry</topic><topic>Health services</topic><topic>Legislatures</topic><topic>Patients</topic><topic>Pharmaceutical industry</topic><topic>Pharmacists</topic><topic>Prices</topic><topic>Profits</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>"Buddy" Carter, Earl L</creatorcontrib><collection>PAIS Index</collection><collection>Worldwide Political Science Abstracts</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><jtitle>Harvard journal on legislation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>"Buddy" Carter, Earl L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PULLING BACK THE CURTAIN ON PBMS: A PATH TOWARDS AFFORDABLE PRESCRIPTION DRUGS</atitle><jtitle>Harvard journal on legislation</jtitle><date>2022-07-01</date><risdate>2022</risdate><volume>59</volume><issue>2</issue><spage>257</spage><pages>257-</pages><issn>0017-808X</issn><eissn>1943-507X</eissn><abstract>Prescription drug prices in the United States continue to rise with no end in sight. Individuals are foregoing other needs to pay for their medicines while healthcare companies continue to rake in enormous profits. In this Essay, I discuss how Americans can reverse this oppressive drug pricing trend. As both a pharmacist and a member of Congress, I explain why drug prices are so high from a unique perspective, and illuminate what patients and Congress can do to bring prices down and advocate for a better system. After discussing various actors involved with prescription drug pricing, this Essay then focuses on Pharmacy Benefit Managers ("PBMs") as the clandestine menace of the healthcare industry. This Essay utilizes first-hand stories from patients, pharmacists, and doctors to illustrate why PBMs need to be exposed and held accountable. Most importantly, this Essay will provide a legislative framework for making lower drug prices a reality.</abstract><cop>Cambridge</cop><pub>Harvard University Law School - Harvard Journal on Legislation</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0017-808X |
| ispartof | Harvard journal on legislation, 2022-07, Vol.59 (2), p.257 |
| issn | 0017-808X 1943-507X |
| language | eng |
| recordid | cdi_proquest_journals_2705443254 |
| source | PAIS Index; Worldwide Political Science Abstracts; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; HeinOnline Law Journal Library |
| subjects | Drug prices Health care industry Health services Legislatures Patients Pharmaceutical industry Pharmacists Prices Profits |
| title | PULLING BACK THE CURTAIN ON PBMS: A PATH TOWARDS AFFORDABLE PRESCRIPTION DRUGS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T00%3A02%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PULLING%20BACK%20THE%20CURTAIN%20ON%20PBMS:%20A%20PATH%20TOWARDS%20AFFORDABLE%20PRESCRIPTION%20DRUGS&rft.jtitle=Harvard%20journal%20on%20legislation&rft.au=%22Buddy%22%20Carter,%20Earl%20L&rft.date=2022-07-01&rft.volume=59&rft.issue=2&rft.spage=257&rft.pages=257-&rft.issn=0017-808X&rft.eissn=1943-507X&rft_id=info:doi/&rft_dat=%3Cproquest%3E2705443254%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2705443254&rft_id=info:pmid/&rfr_iscdi=true |